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Abstract
Background: To investigate the significance of lipid disorders and endothelial dysfunction in
the pathogenesis of microvascular angina.
Methods: Levels of plasma lipids, lipoproteins and apolipoproteins were assessed in 21 patients
with microvascular angina and 24 healthy subjects as controls. Also, the endothelium-depend-
ent vasodilatation function was determined with high-resolution ultrasound in both groups.
Results: Levels of serum total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C),
apolipoprotein B100 (ApoB100) and lipoprotein(a) [Lp(a)] in microvascular angina group
were significantly higher than those in healthy subjects (each p < 0.05). The flow-mediated
dilatation (FMD) in brachial arteries in patients with microvascular angina declined signifi-
cantly as compared with that in control subjects (4.7 ± 1.9% vs. 12.8 ± 3.7%, p < 0.001).
However, no significant difference was observed in response to nitroglycerin between groups
(19.7 ± 8.1% vs. 21.2 ± 6.6%; p > 0.05). Linear correlation analysis revealed a significant
negative correlation between the FMD of brachial arteries and the serum levels of LDL-C and
Lp(a) in the microvascular angina group (r = –0.5125 and –0.4271, respectively, both p <
< 0.001). Subsequently, all subjects were pooled and divided into two groups (groups A and B)
according to the degree of FMD in brachial arteries (A £ 4% and B > 4%). The serum LDL-C
level was found to be significantly higher in group A than in group B (4.09 ± 0.65 mmol/L vs.
2.59 ± 0.49 mmol/L; p < 0.05).
Conclusions: Plasma lipid disorders and vascular endothelial dysfunction may play impor-
tant roles in the development of microvascular angina. The dysfunction of endothelium-
-dependent vasodilation was mainly associated with anomalies in LDL-C and Lp(a), and
myocardial endothelial dysfunction was aggravated by lipid abnormalities in patients with
microvascular angina. (Cardiol J 2008; 15:  324–328)
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Introduction
Microvascular angina has recently been disco-
vered as a new type of angina. Patients with this
condition have symptoms of typical exertional an-
gina with a positive exercise test along with nor-
mal coronary angiography and left ventricular func-
tion, but without large coronary artery spasm, extra-
cardiac factors or established heart disease. Recent
research has shown that anomalous blood flow re-
serve of the coronary arteries is an important fe-
ature, but mechanisms for this have not been fully
defined though there may be a close association
with lipid disorders and coronary endothelial dys-
function [1, 2]. In this study, we observed changes
in blood lipid levels and changes in vascular endo-
thelial function by high-resolution ultrasound in
patients with microvascular angina to explore the
significance of the two indexes in the pathogenesis
of microvascular angina.
Methods
Subjects
A total of 21 patients [8 males and 13 females,
aged 38–59 years (44 ± 8)] were recruited for the
microvascular angina group. These patients had
been diagnosed with microvascular angina and ad-
mitted to our hospital during the period from May
2003 to October 2007. All patients were selected
according to the following criteria: history of typi-
cal exertional angina pectoris; positive results from
an exercise test, Dobutamine stress test or Holter
monitoring over 24 hours; sparse radioactive areas
on movement and partial or complete refilling of ra-
dioactivity at rest as shown by 201TL myocardial ima-
ging, without radioactive defects; normal coronary
angiography and left ventricular function, with the
exclusion of large coronary artery spasm by nega-
tive ergonovine provocation testing in 16 patients;
exclusion of angina possibly caused by hypertension
and/or hypertensive heart disease, cardiac valve
disease, myocardiopathy, pericarditis, etc. or non-
cardiogenic chest pain caused by diseases of bre-
ast, lung, oesophagus, etc. or myocardial ischemic
factors associated with anemia, diabetes mellitus,
peripheral vascular lesions, etc. The control group
consisted of 24 healthy volunteers, comprising
10 men and 14 women aged 35–60 years (46 ± 10),
who underwent history and physical examination,
electrocardiogram and tests for blood sugar and uric
acid, and heart, kidney and liver function tests. None
of the subjects were permitted to take medicines
for 48 hours prior to testing.
The study was approved by the local bioethi-
cal committe and all patients gave their informed
consent.
Measurement of blood lipid
Venous blood was collected from subjects after
12 h of fasting. Serum was immediately separated
by centrifugation and stored at –70°C for later use.
Serum total triglyceride (TG) and total cholesterol
(TC) were measured by enzymatic methods on an
automatic biochemical analyzer. Serum high-den-
sity lipoprotein-cholesterol (HDL-C) was tested by
magnesium tungstate phosphate sedimentation and
the concentration of low-density lipoprotein-chole-
sterol (LDL-C) was calculated by the Friedewald
formula as follows: LDL-C (mmol/L) = TC – HDL-C
– TG/2.2 (TG < 4.5 mmol/L). Concentrations of
apolipoprotein A1 (ApoA1) and B100 (ApoB100) were
determined by circular immunoprecipitation. The
concentration of lipoprotein(a) [LP(a)] was measu-
red by sandwich ELISA assay.
Examination of vascular endothelial function
All tests were performed by an experienced
ultrasonic doctor without prior knowledge of this
study. Using the methods described previously [3, 4],
we examined the brachial artery flow-mediated di-
lation (FMD) using an Acuson 128XP/10 colour
Doppler sonograph (Acuson, Mountain View, CA,
USA) with a 7.0 MHz array detecting head at an
exploration depth of 4 cm; simultaneous electrocar-
diograph readings were recorded. At the time of
measurement, subjects were in supine position with
right upper extremities abducted 15 degrees and
palms facing upward. The brachial artery 2–15 cm
above the elbow was scanned by two-dimensional
ultrasound imaging and longitudinal sections were
observed. When the arterial intima of both anterior
and posterior walls were most clearly defined, am-
plification was adjusted to satisfactorily identify lu-
men interfaces. At the ventricular diastasis (ECG
showing R wave), the distance between the ante-
rior and posterior intima of the brachial artery was
measured for three different cardiac cycles and the
average was calculated.
Brachial arterial calibre at rest and its changes
in response to reactive hyperemia and sublingual
nitroglycerin were measured in all subjects. Befo-
re the reactive hyperemia test, subjects were allo-
wed to rest for 10 min and the baseline value of ar-
terial calibre (D0) was determined. A sphygmoma-
nometer cuff was placed below the elbow, inflated
to 300 mm Hg and deflated quickly after 4 min. The
brachial arterial calibre (D1) was measured within
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60–90 s of the deflation. Vascular calibre was allo-
wed to return to baseline status after resting for
10 min. Then the subjects were given 0.5 mg sub-
lingual nitroglycerin, and brachial arterial calibre
(D2) was measured after 4 min. All calibre measu-
rements were performed at the same site. Calibre
changes of the brachial artery in response to reac-
tive hyperemia and sublingual nitroglycerin were
expressed as percentages of D0. (D1–D0)/D0 ×
× 100% represents endothelium-dependent, flow-
mediated vasodilation; (D2–D0)/D0 × 100% repre-
sents nitroglycerin-mediated, non-endothelium-
dependent vascular relaxation.
Statistical analysis
SPSS10.0 for Windows statistical software was
utilized to analyze the data and all results expres-
sed as the mean ± standard deviation. Student t test
was employed to determine differences between
the groups. The relationship between plasma lipids
and brachial arterial calibre was determined by li-
near correlation analysis and multivariate linear
stepwise regression analysis. P < 0.05 was regar-
ded as statistically significant.
Results
General information
No significant differences were found betwe-
en the microvascular angina group and control gro-
up with regard to sex and age, systolic and diasto-
lic pressure, body mass index, number of cigarette
smoking subjects, baseline heart rate, blood sugar
and uric acid, hemorheology, etc. (all p > 0.05).
Levels of blood lipids
For fasting levels of TC, LDL-C, ApoB100 and
Lp(a), the microvascular angina group was signifi-
cantly higher than the control group (each p < 0.05).
However, there were no differences in serum TG,
HDL-C and ApoA1 between the groups (p > 0.05,
Table 1).
Changes in brachial arterial calibre
There was no significant difference in the ba-
seline values of brachial arterial calibre between the
microvascular angina and control groups (p > 0.05).
Calibre changes in response to reactive hyperemia
in microvascular angina patients had significantly
decreased as compared with those in healthy con-
trols (p < 0.001). Administration of sublingual ni-
troglycerin led to obvious dilatation of the brachial
artery with no significant difference observed be-
tween the groups (p > 0.05, Table 2).
Association between lipid levels and FMD
Univariate correlation analysis indicated that
brachial artery FMD was inversely related to LDL-C
and Lp(a) levels (r = –0.5125 and –0.4271, respec-
tively, p < 0.001); multivariate stepwise regression
analysis revealed that the plasma level of LDL-C
was the major lipid component influencing FMD.
According to the degree of FMD of the brachial ar-
tery (£ 4% and > 4%), all subjects (n = 45) from
both groups were pooled and then divided into two
groups: group A (n = 25) and group B (n = 20). The
mean FMD for groups A and B were 1.41 ± 1.20%
and 8.35 ± 3.02%, respectively. It was found that
the lipid disorders in group A were dominated by
the increase in LDL-C (4.09 ± 0.65 mmol/L) and
by the decrease in LDL-C in group B (2.59 ±
± 0.49 mmol/L). LDL-C levels differed significan-
tly between the two groups (p < 0.05), while no
significant differences were observed in the other
lipid components (all p > 0.05).
Table 1. Comparison of blood lipids between the
microvascular angina and control groups.
Microvascular Control
angina  group
(n = 21)  (n = 24)
TC [mmol/L] 5.42±0.53* 4.69±0.61
TG [mmol/L] 1.45±0.39 1.46±0.52
LDL-C [mmol/L] 3.98±0.42* 2.56±0.54
HDL-C [mmol/L] 1.43±0.30 1.44±0.47
ApoA1 [g/L] 1.21±0.36 1.23±0.25
ApoB100 [g/L] 1.01±0.37* 1.19±0.18
Lp(a) [mg/L] 282.4±220.3* 161.8±116.5
*Comparison with the control group: p < 0.05; all values are presented
as mean ±SD
Table 2. Comparison of changes in brachial
artery calibre between the microvascular angina
and the control groups.
Microvascular Control
angina group
 (n = 21) (n = 24)
Baseline calibre [mm] 3.79±0.63 3.81±0.50
Flow-mediated 4.7±1.9* 12.8±3.7
dilation (%)
Nitroglycerin-mediated 19.7±8.1 21.2±6.6
dilation (%)
*Comparison with control group: p < 0.001; all values are presented
as mean ±SD
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Discussion
Microvascular angina, characterized mainly by
a reduction in coronary artery dilatation reserve,
differs from coronary artery disease; however, in-
tra-coronary artery ultrasound and Doppler reveal
early changes of coronary atherosclerosis in some
patients displaying focal or eccentric lesions with
pathologically-confirmed fatty deposits, infiltration
of foam cells of macrophage origin, microarterial
fibromuscular hyperplasia, vascular wall thickening,
endothelial degeneration, etc. [5, 6]. The results of
the present study indicated that lipid disorders in
patients with microvascular angina mainly featured
increased levels of TC, LDL-C, ApoB100 and Lp(a),
while TG, HDL-C and ApoA1 were notably unchan-
ged, in accordance with previous reports [7, 8].
Lipid disorders may result in fatty deposits in the
vascular wall including microvessels. As an essen-
tial structural protein of lipoprotein, apolipoprote-
ins are metabolic procedural agents which encode
and regulate lipoprotein metabolism and balance
cholesterol in the body. ApoB100 exerts a strong ef-
fect to stimulate the esterization of cholesterol in
microphages, which promotes foam cell formation.
An elevated Lp(a) level is an independent risk fac-
tor for atherosclerosis. Its unique apolipoprotein,
Apo(a), for the most part outside of the cell, is able
to penetrate through arterial endothelium into the
intima and bind to glycoprotein and collagen fibres
to impair vascular endothelium, which, together
with aberrant lipids, lead to eventual endothelial
dysfunction [9, 10].
Endothelium-dependent vasodilation refers to
vascular relaxation caused by endothelium-derived
relaxing factor (EDRF) released by endothelial cells
in response to physiological stimulations (e.g. re-
active hyperemia) or drugs (e.g. acetylcholine), and
is dependent on the complete structure and normal
function of the vascular endothelium [11, 12]. In
contrast, non-endothelium-dependent vasodilata-
tion refers to that caused by nitric oxide (NO) di-
rectly released by drugs, e.g. nitroglycerin and so-
dium nitroprusside. In this study, we used calibre
changes of the brachial artery in response to reac-
tive hyperemia to reflect changes in endothelium-
dependent vasodilation. Studies have demonstrated
that endothelium-dependent dilation changes in
peripheral vessels not only reflect endothelial func-
tion of peripheral vessels, but also correlate well
with coronary endothelial function; therefore, bra-
chial artery FMD could indirectly reveal coronary
endothelial function in patients with microvascular
angina [13, 14]. Results of this study have demon-
strated marked impairment in endothelium-depen-
dent vasodilation of peripheral brachial arteries in
patients with microvascular angina, with unapparent
changes in non-endothelium-dependent vasodila-
tion, indirectly reflecting the dysfunction of the
coronary endothelium. With the exclusion of large
coronary artery spasm by negative Ergonovine pro-
vocation test, endothelial dysfunction may lead to
a decrease in the reserve of coronary artery dila-
tion and dynamic abnormalities which play an im-
portant role in the development of microvascular
angina.
Conclusions
In the study, LDL-C and Lp(a) levels in serum
were demonstrated to be negatively associated with
endothelium-dependent dilation, and LDL-C was
shown to be the major contributing factor determi-
ned by multivariate analysis. Also, the grouping
study based on the degree of brachial artery FMD
revealed that an elevated LDL-C level was a major
lipid component resulting in the impairment of en-
dothelium-dependent dilation function. These re-
sults suggest that lipid disorders in microvascular
angina aggravate endothelial impairment and have
a role in the pathogenesis of microvascular angina.
Therefore, positive monitoring of the lipid profile
and endothelium-dependent dilation is valuable in
early prophylaxis and diagnosis of microvascular
angina. Balancing plasma lipid levels and protecting
vascular endothelial function are critical in the pre-
vention and cure of microvascular angina.
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